Mengxiang Yang

729 total citations
28 papers, 486 citations indexed

About

Mengxiang Yang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mengxiang Yang has authored 28 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Mengxiang Yang's work include Alzheimer's disease research and treatments (4 papers), RNA modifications and cancer (4 papers) and Seaweed-derived Bioactive Compounds (3 papers). Mengxiang Yang is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), RNA modifications and cancer (4 papers) and Seaweed-derived Bioactive Compounds (3 papers). Mengxiang Yang collaborates with scholars based in China, Denmark and United Kingdom. Mengxiang Yang's co-authors include Wei Cui, Meirong Liu, Jing Zhang, Jun Zhao, Yingxue Li, Jun Zhao, C. Benjamin Naman, Xiaojun Yan, Huanrong Lan and Ketao Jin and has published in prestigious journals such as Advanced Materials, Journal of Agricultural and Food Chemistry and Frontiers in Immunology.

In The Last Decade

Mengxiang Yang

27 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengxiang Yang China 13 219 124 72 71 49 28 486
Ayşegül Çört Türkiye 15 291 1.3× 70 0.6× 75 1.0× 53 0.7× 33 0.7× 25 658
Fang Shi China 17 363 1.7× 175 1.4× 63 0.9× 49 0.7× 69 1.4× 33 762
Shuai Yuan China 13 368 1.7× 166 1.3× 41 0.6× 46 0.6× 63 1.3× 29 597
Huixian Zhang China 14 213 1.0× 72 0.6× 58 0.8× 79 1.1× 22 0.4× 29 539
Ji Hye Im South Korea 16 315 1.4× 134 1.1× 121 1.7× 36 0.5× 58 1.2× 28 605
Antonietta Notaro Italy 14 318 1.5× 78 0.6× 54 0.8× 38 0.5× 90 1.8× 30 633
Lu Wen China 12 272 1.2× 96 0.8× 97 1.3× 60 0.8× 42 0.9× 51 508
Cristina Florean Italy 15 590 2.7× 96 0.8× 98 1.4× 31 0.4× 89 1.8× 17 861
Federica Vannini United States 5 222 1.0× 143 1.2× 78 1.1× 108 1.5× 38 0.8× 6 526
Sarita G. Menon United States 10 455 2.1× 92 0.7× 91 1.3× 49 0.7× 43 0.9× 12 699

Countries citing papers authored by Mengxiang Yang

Since Specialization
Citations

This map shows the geographic impact of Mengxiang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengxiang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengxiang Yang more than expected).

Fields of papers citing papers by Mengxiang Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengxiang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengxiang Yang. The network helps show where Mengxiang Yang may publish in the future.

Co-authorship network of co-authors of Mengxiang Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Mengxiang Yang. A scholar is included among the top collaborators of Mengxiang Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengxiang Yang. Mengxiang Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Yong, Yang Zang, Mengyu Yuan, et al.. (2025). Biohybrid Microrobot Enteric‐Coated Microcapsule for Oral Treatment of Colorectal Cancer. Advanced Materials. 37(40). e20586–e20586. 3 indexed citations
2.
Yang, Mengxiang, et al.. (2023). Could immunoscore improve the prognostic and therapeutic management in patients with solid tumors?. International Immunopharmacology. 124(Pt B). 110981–110981. 5 indexed citations
3.
Yang, Mengxiang, Qing Li, Qin Zhou, et al.. (2023). Drought priming mechanisms in wheat elucidated by in-situ determination of dynamic stomatal behavior. Frontiers in Plant Science. 14. 1138494–1138494. 14 indexed citations
4.
Zheng, Zhijian, Wenxia Xu, Mengxiang Yang, et al.. (2023). Downregulation of AC092894.1 promotes oxaliplatin resistance in colorectal cancer via the USP3/AR/RASGRP3 axis. BMC Medicine. 21(1). 132–132. 24 indexed citations
5.
Yang, Mengxiang, et al.. (2023). It’s high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancer. Frontiers in Immunology. 14. 1241208–1241208. 3 indexed citations
6.
Yang, Mengxiang, et al.. (2023). Integration of liquid biopsy and immunotherapy: opening a new era in colorectal cancer treatment. Frontiers in Immunology. 14. 1292861–1292861. 11 indexed citations
7.
Lan, Huanrong, et al.. (2023). From organ preservation to selective surgery: How immunotherapy changes colorectal surgery?. Surgery Open Science. 15. 44–53. 5 indexed citations
8.
Lan, Huanrong, You-Ni Zhang, Mengxiang Yang, et al.. (2023). Multifunctional nanocarriers for targeted drug delivery and diagnostic applications of lymph nodes metastasis: a review of recent trends and future perspectives. Journal of Nanobiotechnology. 21(1). 247–247. 24 indexed citations
9.
Wang, Qiyao, Difan Zhang, Jiani Lu, et al.. (2022). PLGA-PEG-fucoxanthin nanoparticles protect against ischemic stroke in vivo. Journal of Functional Foods. 99. 105359–105359. 3 indexed citations
10.
Yang, Mengxiang, Zhuoying Wu, Panpan Zhang, et al.. (2021). PLGA-PEG Nanoparticles Facilitate In Vivo Anti-Alzheimer’s Effects of Fucoxanthin, a Marine Carotenoid Derived from Edible Brown Algae. Journal of Agricultural and Food Chemistry. 69(34). 9764–9777. 53 indexed citations
11.
Ma, Dan, et al.. (2020). MicroRNA-18a induces epithelial-mesenchymal transition like cancer stem cell phenotype via regulating RKIP pathway in pancreatic cancer. Annals of Translational Medicine. 8(7). 433–433. 10 indexed citations
12.
Yang, Mengxiang, et al.. (2020). CSB6B prevents β-amyloid-associated neuroinflammation and cognitive impairments via inhibiting NF-κB and NLRP3 in microglia cells. International Immunopharmacology. 81. 106263–106263. 31 indexed citations
13.
Wu, Wenwen, et al.. (2020). Circular RNA circ‑ACACA regulates proliferation, migration and glycolysis in non‑small‑cell lung�carcinoma via miR‑1183 and PI3K/PKB pathway. International Journal of Molecular Medicine. 45(6). 1814–1824. 26 indexed citations
14.
Yang, Mengxiang, Zhuoying Wu, Xiao Xiao, et al.. (2020). Evans Blue Might Produce Pathologically Activated Neuroprotective Effects via the Inhibition of the P2X4R/p38 Signaling Pathway. Cellular and Molecular Neurobiology. 41(2). 293–307. 7 indexed citations
15.
Huang, Liming, Lijian Ding, Xiaohui Li, et al.. (2019). A new lateral root growth inhibitor from the sponge-derived fungus Aspergillus sp. LS45. Bioorganic & Medicinal Chemistry Letters. 29(13). 1593–1596. 12 indexed citations
16.
Wang, Bao‐Zhong, et al.. (2019). MTA1 promotes the invasion and migration of oral squamous carcinoma by inducing epithelial–mesenchymal transition via the hedgehog signaling pathway. Experimental Cell Research. 382(1). 111450–111450. 15 indexed citations
17.
18.
Xu, Peng, Haijie Li, Mengxiang Yang, et al.. (2019). 25C-NBOMe, a Novel Designer Psychedelic, Induces Neurotoxicity 50 Times More Potent Than Methamphetamine In Vitro. Neurotoxicity Research. 35(4). 993–998. 19 indexed citations
19.
Zhang, Jing, et al.. (2017). Puerarin inhibits M2 polarization and metastasis of tumor-associated macrophages from NSCLC xenograft model via inactivating MEK/ERK 1/2 pathway. International Journal of Oncology. 50(2). 545–554. 68 indexed citations
20.
Zhang, Jing, et al.. (2016). Significance of stem cell marker Nanog gene in the diagnosis and prognosis of lung cancer. Oncology Letters. 12(4). 2507–2510. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayşegül Çört Breakdown of academic impact, for papers by Fang Shi Breakdown of academic impact, for papers by Shuai Yuan Breakdown of academic impact, for papers by Huixian Zhang Breakdown of academic impact, for papers by Ji Hye Im Breakdown of academic impact, for papers by Antonietta Notaro Breakdown of academic impact, for papers by Lu Wen Breakdown of academic impact, for papers by Cristina Florean Breakdown of academic impact, for papers by Federica Vannini Breakdown of academic impact, for papers by Sarita G. Menon
Rankless by CCL
2026